Stay up-to-date on the companies, people and issues that impact businesses in Syracuse, Central New York and beyond.
PAR completes sale of logistics-management subsidiary
NEW HARTFORD — PAR Technology Corp. (NYSE: PAR) completed the asset sale of its PAR Logistics Management Systems (PAR LMS) subsidiary to ORBCOMM, Inc. (NASDAQ:
CVI takes over Sheltered Workshop services
BINGHAMTON — Johnson City–based Country Valley Industries (CVI) has taken over as service and contract provider for Sheltered Workshop’s location at 203 Court St. in
N.Y. manufacturers’ business conditions improve again in January
New York manufacturers reported improving business conditions in January, including increasing orders and higher selling prices, according to a survey from the Federal Reserve Bank
Welch Allyn fills two chief officer spots
SKANEATELES FALLS — Welch Allyn has appointed two employees to chief officer positions, the medical-device manufacturer said today. The company named Scott Gucciardi executive vice
FAA awards Sensis new contract worth up to $119M
DeWITT — Saab Sensis Corp. won a contract worth up to $119 million from the Federal Aviation Administration (FAA) to deploy a combination of technology
Plans move forward for Ithaca-area wind farm
ENFIELD — Pipestone, Minn.–based Juhl Wind, Inc. signed a development services agreement with Black Oak Wind Farm, LLC near Ithaca for a proposed 15 to
New York manufacturing conditions keep rising in January
Business conditions for New York Manufacturers continued to swing upward in January, according to the Federal Reserve Bank of New York’s monthly Empire State Manufacturing
O’Brien & Gere acquires S.C. firm
SYRACUSE – Syracuse-based O’Brien & Gere has acquired the remaining 55 percent ownership of the architecture and engineering firm Lindbergh & Associates of North Charleston,
Malvaso to retire from Toyota Material Handling North America
GREENE — James J. Malvaso, president and CEO of Toyota Material Handling North America (TMHNA), the parent company of The Raymond Corp., will retire effective
Bristol-Myers Squibb to acquire Georgia drug developer
NEW YORK — The biopharmaceutical maker Bristol-Myers Squibb Co. has reached an agreement to acquire clinical-stage biopharmaceutical company Inhibitex, Inc. Bristol-Myers (NYSE: BMY), based in
Stay up-to-date on the companies, people and issues that impact businesses in Syracuse, Central New York and beyond.